Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-11-019495)

Filing Details

Accession Number:: 0001209191-11-019495
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-03-24 13:26:38
Reporting Period:: 2011-03-23

Filing Date:: 2011-03-24
Accepted Time:: 2011-03-24 13:26:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1190290	Elaine Ullian	C/O Vertex Pharmaceuticals Incorporated 130 Waverly St Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-03-23	7,500	$44.47	12,500	No	4	M	Direct
Common Stock	Disposition	2011-03-23	7,235	$46.08	5,265	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2011-03-23	7,500	$0.00	7,500	$44.47

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2001-06-01	2011-05-31	No	4	M	Direct

Footnotes

Open market sales reported on this line occurred at a weighted average price of $46.08 (range $46.07 to $46.11).
Ms. Ullian undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.